drugset / Trial / NCT00641680

Rhinocort Aqua Versus Placebo and Fluticasone Propionate

NCT00641680

Phase 3 Completed 750 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare once daily treatment with Rhinocort against placebo and Fluticasone Propionate at reliving the nasal symptoms of seasonal allergic rhinitis.

Timeline

Start
2003-04
Primary completion
2003-07
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule
Comparator Fluticasone propionate Other / unclassified